Leonardus H.t. van der Ploeg, Chief Scientific Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 65,600 shares at $27.45 ($1.9M) on 2018-09-25, disclosed to the SEC on 2018-09-27.
Open-market sale of $1.9M RYTM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,000 | $0 | 0.0% |
| 2 | $27.45 | 3,686 | $101K | 5.3% |
| 3 | $27.45 | 3,686 | $101K | 5.3% |
| 4 | $28.88 | 9,052 | $261K | 13.8% |
| 5 | $28.88 | 9,052 | $261K | 13.8% |
| 6 | $29.81 | 7,656 |
| $228K |
| 12.0% |
| 7 | $29.81 | 7,656 | $228K | 12.0% |
| 8 | $30.60 | 5,304 | $162K | 8.6% |
| 9 | $30.60 | 5,304 | $162K | 8.6% |
| 10 | $31.86 | 6,102 | $194K | 10.3% |
| 11 | $31.86 | 6,102 | $194K | 10.3% |
| Total | $28.89 avg | 65,600 | $1.9M | 100% |
| Filing → |
| RYTM | SELL | 2019-01-18 | $6K | — | Filing → |
| RYTM | SELL | 2018-11-06 | $1.1M | — | Filing → |